Results for tag: "Edaravone"

Edaravone is a drug used to treat neurological disorders, primarily those related to the central nervous system. It is used to treat conditions such as amyotrophic lateral sclerosis (ALS), stroke, and Parkinson's disease. Edaravone works by reducing oxidative stress, which is believed to be a major contributor to the progression of these diseases. It is administered intravenously and is typically given in a series of treatments over a period of time. Edaravone is a relatively new drug, having been approved by the US Food and Drug Administration in 2017. It is currently approved for use in Japan, South Korea, and the United States. In Japan, it is the only approved drug for the treatment of ALS. The Edaravone market is growing rapidly, as it is becoming increasingly recognized as an effective treatment for neurological disorders. It is expected to continue to grow in the coming years, as more countries approve its use and more research is conducted on its efficacy. Some companies in the Edaravone market include Mitsubishi Tanabe Pharma Corporation, Teva Pharmaceutical Industries, and Mylan N.V. Show Less Read more